Larger than Life Science: Putting Your Best Foot Forward - Connecting with Pharma Partners and VCs hosted by LaunchBio
Life science startups need strong partnerships to thrive. Making a meaningful connection to a pharma partner or key investor at the right time can be the difference between a fast track to growth or languishing in the lab. These partnerships bring not only much-needed capital, but also invaluable introductions and industry insights.
We are excited to offer this special program led by Jim Greenwood, former CEO of BIO and now Senior Policy Advisor at DLA Piper, who will help companies understand what VCs and strategic alliance partners are looking for as they evaluate startups and founding teams. Joining him will be Laura Stoppel, Principal at RA Capital Management, a leading life sciences venture capital fund; and Jason Hafler, Managing Director, Sanofi Ventures, representing a corporate venture group.
The discussion will cover the importance of modifying your elevator pitch to align with the interest of your audience, the need to invest time in researching partners and building relationships, and some pro tips on what to do to make a good first impression. The program is designed for early stage life science companies planning to raise capital or pursue an alliance with a pharma partner in the next 12-18 months.